Bio-Techne Corporation
IT ˙ BIT ˙ US09073M1045
54,00 € 0,00 (0,00%)
2026-06-03
AKTIENPREIS
SecurityIT:1TECH / Bio-Techne Corporation
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership1,025,105 shares
Latest Disclosed Value $ 53,346,504
Jpmorgan Chase & Co ownership in 1TECH / Bio-Techne Corporation

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 1,025,105 shares of Bio-Techne Corporation (IT:1TECH) valued at $55,355,670 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 759,082 shares of Bio-Techne Corporation. This represents a change in shares of 35.05% during the quarter. The current value of the position is $55,355,670 USD.

Jpmorgan Chase & Co has a history of taking positions in derivatives of the underlying security (1TECH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1TECH / Bio-Techne Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BIO-TECHNE COMMON 09073M104 1,025,105 266,023 35.05 53,347 19.50 0.0004
2026-02-11 2025-12-31 13F BIO-TECHNE COMMON 09073M104 759,082 33,997 4.69 44,642 10.67 0.0028
2025-11-26 2025-09-30 13F/A-1 BIO-TECHNE COMMON 09073M104 725,085 -633,738 -46.64 40,337 -42.30 0.0024
2025-11-07 2025-09-30 13F BIO-TECHNE COMMON 09073M104 725,085 -633,738 40,337 0.0003
2025-08-12 2025-06-30 13F BIO-TECHNE COMMON 09073M104 1,358,823 470,339 52.94 69,911 34.21 0.0046
2025-05-12 2025-03-31 13F BIO-TECHNE COMMON 09073M104 888,484 363,384 69.20 52,092 37.73 0.0038
2025-02-12 2024-12-31 13F BIO-TECHNE COMMON 09073M104 525,100 -231,084 -30.56 37,823 -37.42 0.0028
2024-12-26 2024-09-30 13F/A-1 BIO TECHNE COMMON 09073M104 756,184 -150,782 -16.62 60,442 -6.99 0.0046
2024-11-08 2024-09-30 13F BIO TECHNE COMMON 09073M104 756,184 -150,782 60,442 0.0046
2024-12-26 2024-06-30 13F/A-1 BIO-TECHNE COMMON 09073M104 906,966 185,206 25.66 64,984 27.91 0.0053
2024-08-12 2024-06-30 13F BIO-TECHNE COMMON 09073M104 906,966 185,206 64,984 0.0053
2024-12-26 2024-03-31 13F/A-1 Bio Techne COMMON 09073M104 721,760 158,899 28.23 50,805 16.98 0.0043
2024-05-10 2024-03-31 13F Bio Techne COMMON 09073M104 721,760 158,899 50,805 0.0043
2024-12-26 2023-12-31 13F/A-1 BIO-TECHNE COMMON 09073M104 562,861 -38,346 -6.38 43,430 6.12 0.0042
2024-02-12 2023-12-31 13F BIO-TECHNE COMMON 09073M104 562,861 -38,346 43,430 0.0042
2023-11-14 2023-09-30 13F BIO-TECHNE COMMON 09073M104 601,207 -46,495 -7.18 40,924 -22.60 0.0045
2023-08-11 2023-06-30 13F BIO-TECHNE COMMON 09073M104 647,702 86,717 15.46 52,872 27.03 0.0057
2023-05-18 2023-03-31 13F/A-1 BIO-TECHNE COMMON 09073M104 560,985 40,902 7.86 41,621 96,693.02 0.0051
2023-05-11 2023-03-31 13F BIO-TECHNE COMMON 09073M104 486,966 -33,117 41,621 0.0006
2023-02-13 2022-12-31 13F BIO-TECHNE COMMON 09073M104 520,083 375,416 259.50 43 -99.90 0.0057
2022-11-14 2022-09-30 13F BIO-TECHNE COMMON 09073M104 144,667 -6,661 -4.40 41,084 -21.68 0.0059
2022-08-11 2022-06-30 13F BIO-TECHNE COMMON 09073M104 151,328 -1,221 -0.80 52,457 -20.59 0.0073
2022-05-11 2022-03-31 13F BIO-TECHNE COMMON 09073M104 152,549 -8,542 -5.30 66,058 -20.74 0.0080
2022-02-11 2021-12-31 13F/A-1 BIO-TECHNE COMMON 09073M104 161,091 -56,093 -25.83 83,340 -20.81 0.0096
2022-02-10 2021-12-31 13F BIO-TECHNE COMMON 09073M104 161,091 -56,093 83,340 0.0095
2021-11-12 2021-09-30 13F BIO-TECHNE COMMON 09073M104 217,184 -138 -0.06 105,240 7.55 0.0130
2021-08-12 2021-06-30 13F BIO-TECHNE COMMON 09073M104 217,322 8,324 3.98 97,851 22.58 0.0117
2021-05-12 2021-03-31 13F BIO-TECHNE COMMON 09073M104 208,998 51,521 32.72 79,823 59.62 0.0107
2021-02-19 2020-12-31 13F/A-1 BIO-TECHNE COMMON 09073M104 157,477 44,700 39.64 50,008 79.70 0.0073
2021-02-11 2020-12-31 13F BIO-TECHNE COMMON 09073M104 157,477 44,700 50,008 1,236.7335
2020-11-12 2020-09-30 13F/A-1 BIO-TECHNE COMMON 09073M104 112,777 15,144 15.51 27,828 7.94 0.0047
2020-11-12 2020-09-30 13F BIO-TECHNE COMMON 09073M104 112,777 27,828
2020-08-11 2020-06-30 13F BIO-TECHNE COMMON 09073M104 97,633 24,171 32.90 25,782 85.08 0.0050
2020-05-12 2020-03-31 13F BIO-TECHNE COMMON 09073M104 73,462 5,562 8.19 13,930 -6.54 0.0033
2020-02-11 2019-12-31 13F BIO TECHNE COMMON 09073M104 67,900 -2,714 -3.84 14,904 7.86 0.0028
2019-11-12 2019-09-30 13F BIO TECHNE COMMON 09073M104 70,614 28,578 67.98 13,818 59.27 0.0028
2019-08-07 2019-06-30 13F BIO TECHNE COMMON 09073M104 42,036 -2,828 -6.30 8,676 -2.62 0.0017
2019-05-07 2019-03-31 13F BIO TECHNE COMMON 09073M104 44,864 1,821 4.23 8,909 43.00 0.0018
2019-02-11 2018-12-31 13F BIO TECHNE COMMON 09073M104 43,043 -33,813 -44.00 6,230 -60.28 0.0014
2018-11-13 2018-09-30 13F/A-1 BIO TECHNE COMMON 09073M104 76,856 8,480 12.40 15,686 55.06 0.0030
2018-11-07 2018-09-30 13F BIO TECHNE COMMON 09073M104 76,856 8,480 15,686
2018-08-14 2018-06-30 13F BIO TECHNE COMMON 09073M104 68,376 -169 -0.25 10,116 -2.29 0.0021
2018-05-10 2018-03-31 13F BIO TECHNE COMMON 09073M104 68,545 25,451 59.06 10,353 85.44 0.0022
2018-02-13 2017-12-31 13F BIO TECHNE COMMON 09073M104 43,094 41,867 3,412.14 5,583 3,672.30 0.0012
2017-11-09 2017-09-30 13F BIO TECHNE COMMON 09073M104 1,227 -4,807 -79.67 148 -79.13 0.0000
2017-08-09 2017-06-30 13F BIO TECHNE COMMON 09073M104 6,034 5,246 665.74 709 786.25 0.0002
2017-05-10 2017-03-31 13F BIO TECHNE COMMON 09073M104 788 -5,831 -88.09 80 -88.25 0.0000
2017-02-06 2016-12-31 13F BIO TECHNE COMMON 09073M104 6,619 4,737 251.70 681 228.99 0.0002
2016-11-04 2016-09-30 13F BIO TECHNE COMMON 09073M104 1,882 -1,883 -50.01 207 -51.18 0.0001
2016-08-08 2016-06-30 13F BIO TECHNE COMMON 09073M104 3,765 601 18.99 424 41.33 0.0001
2016-05-10 2016-03-31 13F BIO TECHNE COMMON 09073M104 3,164 1,392 78.56 300 87.50 0.0001
2016-02-12 2015-12-31 13F BIO TECHNE COMMON 09073M104 1,772 -1,226 -40.89 160 -42.24 0.0000
2015-11-13 2015-09-30 13F BIO TECHNE COMMON 09073M104 2,998 2,998 69.19 277 73.13 0.0001
2015-08-14 2015-06-30 13F BIO-TECHNE COMMON 09073M104 0 -16,806 -100.00 0 -100.00
2015-05-15 2015-03-31 13F BIO-TECHNE COMMON 09073M104 16,806 -32,293 -65.77 1,686 -62.84 0.0004
2015-02-13 2014-12-31 13F BIO-TECHNE COMMON 09073M104 49,099 39,327 402.45 4,537 396.39 0.0010
2014-12-08 2014-09-30 13F/A-1 TECHNE COMMON 878377100 9,772 -16,368 -62.62 914 -62.25 0.0002
2014-11-14 2014-09-30 13F TECHNE COMMON 878377100 9,772 914
2014-09-03 2014-06-30 13F/A-1 TECHNE COMMON 878377100 26,140 9,432 56.45 2,421 69.89 0.0006
2014-08-14 2014-06-30 13F TECHNE COMMON 878377100 26,140 2,421
2014-05-15 2014-03-31 13F TECHNE COMMON 878377100 16,708 -9,586 -36.46 1,425 -42.73 0.0004
2014-02-26 2013-12-31 13F/A-1 TECHNE COMMON 878377100 26,294 4,300 19.55 2,488 41.28 0.0007
2014-02-13 2013-12-31 13F TECHNE COMMON 878377100 26,294 2,488
2013-10-31 2013-09-30 13F TECHNE COMMON 878377100 21,994 1,028 4.90 1,761 21.53 0.0005
2013-08-13 2013-06-30 13F TECHNE COMMON 878377100 20,966 20,966 1,449 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-08 2024-09-30 13F BIO-TECHNE OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-12-26 2024-06-30 13F/A BIO-TECHNE OPTION Call 130,000 9,314 n/a n/a n/a
2024-08-12 2024-06-30 13F BIO-TECHNE OPTION Call 130,000 9,314 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.